Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Cancer Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT03992885
What this trial is testing

Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 70
Not applicableLooking for participantsNCT06648317
What this trial is testing

Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions

Who this might be right for
Lung Cancer, Non-Small CellLung Infection
Peking University Cancer Hospital & Institute 20
Early research (Phase 1)Study completedNCT00107250
What this trial is testing

AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)

Who this might be right for
Colorectal CancerLung CancerUnspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 50
Testing effectiveness (Phase 2)Study completedNCT00051974
What this trial is testing

Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Millennium Pharmaceuticals, Inc. 155
Not applicableStudy completedNCT02965391
What this trial is testing

Dynamic Changes of Circulating Tumor DNA in Surgical Lung Cancer Patients

Who this might be right for
CarcinomaNon-small-cell Lung CancerLung Neoplasms
Peking University People's Hospital 20
Large-scale testing (Phase 3)Active Not RecruitingNCT02193282
What this trial is testing

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

Who this might be right for
Lung Non-Squamous Non-Small Cell CarcinomaStage IB Lung Non-Small Cell Carcinoma AJCC v7Stage II Lung Non-Small Cell Cancer AJCC v7+3 more
National Cancer Institute (NCI) 390
Testing effectiveness (Phase 2)Ended earlyNCT02954523
What this trial is testing

Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations

Who this might be right for
EGFR Gene MutationNonsmall Cell Lung Cancer
Chul Kim 10
Not applicableLooking for participantsNCT05557552
What this trial is testing

Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage III
Ruijin Hospital 56
Testing effectiveness (Phase 2)WithdrawnNCT04758949
What this trial is testing

FL-101 in Surgically Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Flame Biosciences
Not applicableStudy completedNCT02777658
What this trial is testing

PANORAMA - Real World Molecular Testing, Treatment Patterns, and Clinical Outcomes EGFR Mutation-Positive NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 169
Testing effectiveness (Phase 2)Ended earlyNCT00290550
What this trial is testing

A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 22
Testing effectiveness (Phase 2)Looking for participantsNCT04270591
What this trial is testing

Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer

Who this might be right for
C-Met Exon 14 Mutation
Haihe Biopharma Co., Ltd. 183
Not applicableNot Yet RecruitingNCT06202690
What this trial is testing

SP Robotic Versus VATS Anatomical Pulmonary Resection for Patients With NSCLC

Who this might be right for
RoboticsLung Cancer
Korea University Guro Hospital 290
Testing effectiveness (Phase 2)Study completedNCT00892710
What this trial is testing

Trial of Poor Performance Status Patients (ToPPS)

Who this might be right for
Non Small Cell Lung Cancer
SCRI Development Innovations, LLC 172
Testing effectiveness (Phase 2)Study completedNCT00006004
What this trial is testing

Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Eastern Cooperative Oncology Group
Not applicableStudy completedNCT04629300
What this trial is testing

Supportive Care Mobile Application for Patients With NSCLC

Who this might be right for
Non Small Cell Lung CancerQuality of LifeCoping Skills
Massachusetts General Hospital 120
Testing effectiveness (Phase 2)Study completedNCT00217698
What this trial is testing

Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Swiss Cancer Institute 63
Not applicableStudy completedNCT01343914
What this trial is testing

An Observational Study on Patients With Non-Squamous NSCLC Who Reached A Long PFS After Avastin (Bevacizumab)-Based First-Line Therapy

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 118
Early research (Phase 1)Study completedNCT01839955
What this trial is testing

Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Neelesh Sharma MD PhD 12
Large-scale testing (Phase 3)UnknownNCT02633189
What this trial is testing

Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung Cancer

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
National Cancer Institute, Naples 200
Next Page